Search Results

You are looking at 1 - 1 of 1 items for

  • Author: M Royuela x
  • Refine by access: Content accessible to me x
Clear All Modify Search
M Royuela
Search for other papers by M Royuela in
Google Scholar
PubMed
Close
,
MP de Miguel
Search for other papers by MP de Miguel in
Google Scholar
PubMed
Close
,
FR Bethencourt
Search for other papers by FR Bethencourt in
Google Scholar
PubMed
Close
,
M Sanchez-Chapado
Search for other papers by M Sanchez-Chapado in
Google Scholar
PubMed
Close
,
B Fraile
Search for other papers by B Fraile in
Google Scholar
PubMed
Close
,
MI Arenas
Search for other papers by MI Arenas in
Google Scholar
PubMed
Close
, and
R Paniagua
Search for other papers by R Paniagua in
Google Scholar
PubMed
Close

Two different estrogen receptors (ER-alpha and ER-beta) have been described, which are differentially involved in regulating the normal function of reproductive tissues. ER-alpha was considered for a long time to be the only estrogen receptor, and it has been detected in the stromal cells of the human prostate but not in the epithelium. To obtain new information about the differential effects of both receptor types, we have investigated their localization in normal prostates, benign prostatic hyperplasia (BPH), and prostatic cancer (PC) by immunohistochemistry, ELISA and Western blot. Epithelial immunostaining was absent in normal prostates and was present in BPH (10% of cells) and PC (80% of cells), whereas about 15% of stromal cells were positively immunostained for ER-alpha in the three types of prostatic specimens studied. Epithelial immunostaining for ER-beta was detected in normal prostates (13% of cells), BPH (30% of cells) and PC (79% of cells), whereas stromal immunostaining for ER-beta was absent in normal and hyperplastic prostates and was present in PC (12% of cells). The complementary presence of both receptor types in the normal prostate (ER-beta in the epithelium and ER-alpha in the stroma) might explain the mechanism of estrogen action in the development of BPH. The increased epithelial immunostaining for both ER-alpha and ER-beta in BPH and PC suggests that the involvement of estrogen receptors in hyperplasia and cancer concerns mainly the epithelium.

Free access